Sources say Pfizer (PFE -0.1%) will pay a record $2.3B to settle civil and criminal charges over its marketing of Bextra and other drugs. That's in line with the charge Pfizer took in January. Update: Confirmed. Pfizer will plead guilty to one felony for misbranding Bextra; the settlment resolves 'all pending matters.'